About Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome is a rare disease catalogued by Orphanet (ORPHA:46532). It is associated with the HBB, HBG1, HBG2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome trials.
Search ClinicalTrials.gov for "Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome" or filter by Orphanet code ORPHA:46532 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome. Updated daily.